Organ complications after CD19 CAR T-Cell therapy for large B cell lymphoma. a retrospective study from the EBMT Transplant Complications and Lymphoma Working Partys
Authors
Penack, O.Peczynski, C.
Koenecke, C.
Polge, E.
Potter, V.
Yakoub-Agha, I.
Fegueux, N.
Daskalakis, M.
Collin, M. P.
Dreger, P.
Kroger, N.
Schanz, U.
Bloor, Adrian
Ganser, A.
Besley, C.
Wulf, G.
Novak, U.
Moiseev, I.
Schoemans, H.
Basak, G. W.
Chabannon, C.
Sureda, A.
Glass, B.
Peric, Z.
Affiliation
Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, BerlinIssue Date
2022
Metadata
Show full item recordCitation
Penack O, Peczynski C, Koenecke C, Polge E, Potter V, Yakoub-Agha I, et al. Organ Complications after CD19 CAR T-Cell Therapy for Large B Cell Lymphoma. a Retrospective Study from the EBMT Transplant Complications and Lymphoma Working Partys. Blood. 2022 Nov;140:10413-5. PubMed PMID: WOS:000893230303184.Journal
BloodDOI
10.1182/blood-2022-169037Additional Links
https://dx.doi.org/10.1182/blood-2022-169037Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2022-169037